Hongjie Yu - Curriculum Vitae#

Education

• Ph.D. Epidemiology and Biostatistics | Huazhong University of Science and Technology (2009–2014)
  
• Master of Public Health | China CDC (2004–2006)
  
• BSc, Preventive Medicine | China Medical University (1989 - 1994)

Professional Appointments

• Professor, School of Public Health, Fudan University (2017 - present)
  
• Director, Division for Infectious Diseases, China CDC (2012 - 2017)
  
• Deputy Director, Office for Disease Control and Emergency Response, China CDC (2006 - 2012)
  
• Guest Researcher, NCIRD, Centers for Disease Control and Prevention, USA (2010 - 2011)
  
• Chief, Respiratory Infectious Disease Department, China CDC (2003 - 2006)

Honors & Memberships

• Global Highly Cited Researcher, Clarivate (2022 - 2025)
  
• World’s Top 2% Scientist, Stanford University (2019 - 2024)
  
• Changjiang Scholar, China Ministry of Education (2016)
  
• Distinguished Young Scholar, NSFC (2016)
  
• Wu-Jieping Paul Janssen Medical-Pharmaceutical Award (2016)
  
• Memberships: WHO Strategic Advisory Group of Experts (SAGE) on Immunization; National Immunization Advisory Committee of China
  

Research Impact

He has published >290 articles in international peer-review journals, including Science (3), Lancet (5), NEJM (1), BMJ (3), Nat Med (1), Nat Genet (1), Nat Microb (1), Nat Hum Behav (1), Nat Com (11), Cell Res (1), Sci Adv (1), PNAS (2), PLoS Med (4), Lancet Infect Dis (7), Lancet Microb (2), Lancet Glob Health (1) as the first author or senior corresponding author.

Selected Publications

1.[…] Yu H (2024). COVID-19 pandemic interventions reshaped the global dispersal of seasonal influenza viruses. Science 386(6722):eadq3003.

2.[…] Yu H (2022). Modeling transmission of SARS-CoV-2 Omicron in China. Nat Med 28(7):1468-1475.

3.[…] Yu H (2022). Global landscape of SARS-CoV-2 genomic surveillance and data sharing. Nat Genet 54(4):499-507.

4.[…] Yu H (2021). Transmission heterogeneities, kinetics, and controllability of SARS-CoV-2. Science 371(6526):eabe2424.

5.[…] Yu H (2020). Global, regional, and national estimates of target population sizes for covid-19 vaccination: descriptive study. BMJ 371:m4704.

6.[…] Yu H (2020). Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China. Science 368(6498):1481-1486.

7.Yu H et al (2014). Effect of closure of live poultry markets on poultry-to-person transmission of avian influenza A H7N9 virus: an ecological study. Lancet 383(9916):541-8.

8.[…] Yu H (2013). Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory-confirmed cases. Lancet 382(9887):129-37.

9.Yu H et al (2013). Human infection with avian influenza A H7N9 virus: an assessment of clinical severity. Lancet 382(9887):138-45.

10.Yu H et al (2010). Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China. BMJ 341:c4779.